Literature DB >> 11006496

Oestrogens and lower urinary tract function.

A Hextall1.   

Abstract

There is increasing evidence from animal and human studies that sex steroids have an important effect on the female lower urinary tract during adult life. Oestrogen receptors have been identified throughout the brain, pontine micturition centre and in the bladder, urethra and pelvic floor. Fluctuations in the circulating level of oestrogens and progesterone occurring during the menstrual cycle and in pregnancy influence the prevalence of urinary symptoms and the results of urodynamic investigation. In addition, the menopause and subsequent oestrogen deficiency have been implicated in the aetiology of a number of urogenital complaints including incontinence, urgency and recurrent urinary tract infection (UTI). However, the use of hormone replacement therapy for these conditions has given conflicting and largely disappointing results. The aim of this paper is to discuss the role of oestrogen in the pathogenesis and treatment of lower urinary tract dysfunction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11006496     DOI: 10.1016/s0378-5122(00)00143-2

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  23 in total

1.  Immunohistochemical analysis of estrogen receptors in the urethra of sexually intact, ovariectomized, and estrogen-substituted ovariectomized sheep.

Authors:  Heinz R Augsburger; Constanze Führer
Journal:  Int Urogynecol J       Date:  2013-12-07       Impact factor: 2.894

Review 2.  Pharmacological treatment of pure stress urinary incontinence: a narrative review.

Authors:  Mariam A Malallah; Tariq F Al-Shaiji
Journal:  Int Urogynecol J       Date:  2015-01-29       Impact factor: 2.894

3.  Dietary phytoestrogen improves relaxant responses to 17-β-estradiol in aged but not ovariectomised rat bladders.

Authors:  Suzzanne J Owen; Helen M Massa; Roselyn B Rose'Meyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-06-22       Impact factor: 3.000

4.  Duloxetine: a new pharmacologic therapy for stress urinary incontinence.

Authors:  Victor W Nitti
Journal:  Rev Urol       Date:  2004

5.  Treatment options for stress urinary incontinence.

Authors:  Eric S Rovner; Alan J Wein
Journal:  Rev Urol       Date:  2004

Review 6.  The effect of sacral neuromodulation on pregnancy: a systematic review.

Authors:  Amr Mahran; Alex Soriano; Ahmed S Safwat; Adonis Hijaz; Sangeeta T Mahajan; Emanuel C Trabuco; Steven W Siegel; Sherif A El-Nashar
Journal:  Int Urogynecol J       Date:  2017-02-03       Impact factor: 2.894

Review 7.  Dilemmas in the management of female stress incontinence: the role of pelvic floor muscle training.

Authors:  Hatzimouratidis Konstantinos; Konstantinidou Eleni; Hatzichristou Dimitrios
Journal:  Int Urol Nephrol       Date:  2006-11-29       Impact factor: 2.370

8.  Risk of urinary incontinence symptoms in oral contraceptive users: a national cohort study from the Swedish Twin Register.

Authors:  Anastasia Iliadou; Ian Milsom; Nancy L Pedersen; Daniel Altman
Journal:  Fertil Steril       Date:  2008-08-15       Impact factor: 7.329

Review 9.  Pharmacotherapy for stress urinary incontinence : present and future options.

Authors:  Norman R Zinner; Stephanie C Koke; Lars Viktrup
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  Estrogen replacement avoids the decrease of bladder innervations in ovariectomized adult virgin rats: in vivo stereological study.

Authors:  Rogerio de Fraga; Paulo Palma; Miriam Dambros; Cassio L Z Riccetto; Carlos Mandarim-de-Lacerda; Ricardo Miyaoka
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.